MedTech Innovator Asia Pacific’s upcoming 2026 program supports startups operating within the medical device, diagnostic, or digital health verticals. They should have their headquarters in the APAC region or demonstrate a strategic interest in the APAC market. The program is open to startups at any stage of development.
Learn more about the program by joining their upcoming information session (Australia focused)
Applications are now open for the MedTech Innovator Asia Pacific 2026 Accelerator Program.
This is your chance to join the region’s premier platform for medtech innovation, where best-in-class startups gain unparalleled exposure and support.
As part of the exclusive 2026 cohort, you’ll benefit from:
Learn more about the program and apply: https://medtechinnovator.asia/apply-apac/
The objective of this grant opportunity is to provide grants of financial assistance to support Australian medical research and medical innovation projects that use novel methods to harness multiple existing data infrastructure types in developing and implementing new approaches for addressing an unmet medical need.
Research proposals should incorporate:
Turning a great medtech idea into a successful, funded product is one of the hardest parts of innovation. This session will help you understand how reimbursement works – and what you can do early to give your technology the best chance of success.
Join Paul Dale, Director of Policy (Reimbursement) at the Medical Technology Association of Australia (MTAA), for a rare opportunity to hear directly from one of Australia’s leading experts in medtech reimbursement.
Paul will provide an overview of how the reimbursement system works, what payers look for, and how early planning supports commercial success.
This free, online event will be held on Wednesday 13 November 2025, 12:00–1:00 PM AEDT, via Zoom.
Who should attend
Ideal for medtech innovators, startups, researchers, and health professionals seeking a clearer understanding of how reimbursement fits into product development and market strategy.
About the series
The VMH Medtech Skills Spotlight Series brings together industry and academic experts to explore essential skills for success in medtech – from regulation and manufacturing to business models and market access.
Join for an afternoon showcasing Western Australian biomaterials and tissue engineering research!
Antimicrobial resistance (or AMR for short) is expected to kill 38 million people by 2050. AMR means that bacteria have learned to be resistant to or untouchable by antibiotics or other antimicrobials, and is the reason why we are seeing more an more infections that are now “untreatable”. A world in which antibiotics have become ineffective would be truly frightening, and we are at a point where WHO has rung the alarm bell of a post-antibiotic era.
Join us in an epic journey that follows Mallory Smith and her battle with AMR as a cystic fibrosis (CF) patient.
Event Details: Salt in My Soul Official Trailer (Watch Here)
Date/Time: Thursday, 6 Nov 2025
Doors open at 5.30pm for a 6pm start. Join us for light refreshments and drinks in the courtyard from 5.30pm.
Location: Hew Roberts Theatre (access to campus via Clifton Street)
Parking: Free parking on Clifton Street available, anytime from 5pm onward (even in bays marked as “staff” or “student”)
Panel De-briefing: The Movie will conclude with a panel discussion from AMR innovators and clinicians, including:
The WA Life Sciences Innovation Hub, Life Sciences WA, and AusBiotech are teaming up again for the Spotlight on 2025, a must-attend end-of-year event celebrating Western Australia’s dynamic life sciences sector.
If you are an innovator, researcher, startup/SME, public sector, or supporter of WA’s life sciences, join in spotlighting the achievements and good news stories from the sector, acknowledge new partnerships and opportunities, and encourage more growth and opportunities in 2025.
Join the waitlist: https://www.eventbrite.com.au/e/spotlight-on-2025-tickets-1736260565089
The Park is a virtual innovation hub led by the Australian Sports Commission (ASC), designed to connect technology-driven companies with the Australian sports sector to tackle key challenges and unlock system-wide value.
The initiative will focus on five foundational challenges:
Through a six-month co-designed program, The Park will bring together selected technology firms, NSO/Ds, and the ASC to accelerate solutions from Technology Readiness Level (TRL) 4 to TRL 8+. Upon completion, the ASC and participating NSO/Ds may pursue further collaboration, procurement, and deployment of proven technologies at scale.
The next Future Health Research and Innovation (FHRI) Fund Open Day will be held on Wednesday 5 November 2025 at Dexus Place (Perth CBD), and ONLINE.
This event marks an important milestone with the official launch of the FHRI Fund Spotlight program, a new initiative designed to highlight priority health challenges and connect researchers, innovators, community and government to drive impact.
The inaugural Spotlight theme is Rheumatic Heart Disease (RHD) – a serious but preventable condition that disproportionately affects Aboriginal people and communities across WA. By placing RHD in the spotlight, the FHRI Fund seeks to strengthen collaboration, partnerships, research and innovation to reduce its devastating health impacts.
The Open Day is also an opportunity for the WA health and medical research and innovation community to hear about the suite of FHRI Fund opportunities that are aligned to the new FHRI Fund Strategy 2025-30. Several FHRI Fund Programs and Initiatives (P&Is) will be launched and the sector will also be provided the forward view of P&I openings across FY25/26 and FY26/27.
The event will be hosted by the Department of Health’s Office of Medical Research and Innovation (OMRI) and will feature presentations from:
Life Sciences WA, For Blue, Innovation Cluster, and the Aquaculture Council of Western Australia Inc. are calling for Innovator Speakers to take the stage at the 2026 BioInnovation Festival Conference, taking place at the Pan Pacific Hotel, Perth on 11 March 2026.
This opportunity is not only for biotech, health, and life sciences, but also agricultural and aquacultural innovations driving impact across Australia and beyond.
This is your chance to share your story if:
🔹 You didn’t present at last year’s Festival Conference, OR
🔹 Your company has had a major development – a deal, product launch, or other significant milestone.
The EOI is open to industry, investors, WA innovators, and mature university-led projects moving toward commercialisation.
Apply here: https://www.bioinnovationfestival.com/speakers/
